China Traditional Chinese Medicine Lists Current Board and Committee Line-up

Bulletin Express07-17

China Traditional Chinese Medicine Holdings Co. Limited released an updated roster of its Board of Directors and detailed the latest composition of its four Board committees as of 17 July 2026.

The Board now comprises 12 directors: • Executive Directors (3): Chairman Guo Jinhong, Li Hongjian and Peng Li. • Non-executive Directors (5): Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun and Huang Hao. • Independent Non-executive Directors (4): Xie Rong, Yu Tze Shan Hailson, Qin Ling and Li Weidong.

Committee leadership and membership are as follows: 1. Audit Committee – chaired by Independent Non-executive Director Xie Rong; members include Yu Tze Shan Hailson, Qin Ling and Li Weidong. 2. Remuneration and Evaluation Committee – chaired by Qin Ling; members are Li Hongjian, Xie Rong, Yu Tze Shan Hailson and Li Weidong. 3. Nomination Committee – chaired by Guo Jinhong; members include Li Hongjian, Xie Rong, Qin Ling and Li Weidong. 4. Strategic Committee – chaired by Guo Jinhong; members comprise Li Hongjian, Peng Li, Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun, Yu Tze Shan Hailson and Qin Ling.

The disclosure clarifies governance responsibilities, identifying two committee chairs from the executive ranks—Guo Jinhong (Nomination and Strategic Committees)—and two from the independent non-executive cohort—Xie Rong (Audit) and Qin Ling (Remuneration and Evaluation). The structure reflects the company’s adherence to Hong Kong corporate governance practices that emphasize independent oversight across key Board functions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183809137?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183809137","market":"hk","top_or_hot":-1,"title":"China Traditional Chinese Medicine Lists Current Board and Committee Line-up","media":"Bulletin Express","content":"<p>China Traditional Chinese Medicine Holdings Co. Limited released an updated roster of its Board of Directors and detailed the latest composition of its four Board committees as of 17 July 2026.</p>\n<p>The Board now comprises 12 directors:\n• Executive Directors (3): Chairman Guo Jinhong, Li Hongjian and Peng Li.  \n• Non-executive Directors (5): Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun and Huang Hao.  \n• Independent Non-executive Directors (4): Xie Rong, Yu Tze Shan Hailson, Qin Ling and Li Weidong.</p>\n<p>Committee leadership and membership are as follows:\n1. Audit Committee – chaired by Independent Non-executive Director Xie Rong; members include Yu Tze Shan Hailson, Qin Ling and Li Weidong.  \n2. Remuneration and Evaluation Committee – chaired by Qin Ling; members are Li Hongjian, Xie Rong, Yu Tze Shan Hailson and Li Weidong.  \n3. Nomination Committee – chaired by Guo Jinhong; members include Li Hongjian, Xie Rong, Qin Ling and Li Weidong.  \n4. Strategic Committee – chaired by Guo Jinhong; members comprise Li Hongjian, Peng Li, Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun, Yu Tze Shan Hailson and Qin Ling.</p>\n<p>The disclosure clarifies governance responsibilities, identifying two committee chairs from the executive ranks—Guo Jinhong (Nomination and Strategic Committees)—and two from the independent non-executive cohort—Xie Rong (Audit) and Qin Ling (Remuneration and Evaluation). The structure reflects the company’s adherence to Hong Kong corporate governance practices that emphasize independent oversight across key Board functions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Traditional Chinese Medicine Lists Current Board and Committee Line-up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Traditional Chinese Medicine Lists Current Board and Committee Line-up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-17 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Traditional Chinese Medicine Holdings Co. Limited released an updated roster of its Board of Directors and detailed the latest composition of its four Board committees as of 17 July 2026.</p>\n<p>The Board now comprises 12 directors:\n• Executive Directors (3): Chairman Guo Jinhong, Li Hongjian and Peng Li.  \n• Non-executive Directors (5): Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun and Huang Hao.  \n• Independent Non-executive Directors (4): Xie Rong, Yu Tze Shan Hailson, Qin Ling and Li Weidong.</p>\n<p>Committee leadership and membership are as follows:\n1. Audit Committee – chaired by Independent Non-executive Director Xie Rong; members include Yu Tze Shan Hailson, Qin Ling and Li Weidong.  \n2. Remuneration and Evaluation Committee – chaired by Qin Ling; members are Li Hongjian, Xie Rong, Yu Tze Shan Hailson and Li Weidong.  \n3. Nomination Committee – chaired by Guo Jinhong; members include Li Hongjian, Xie Rong, Qin Ling and Li Weidong.  \n4. Strategic Committee – chaired by Guo Jinhong; members comprise Li Hongjian, Peng Li, Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun, Yu Tze Shan Hailson and Qin Ling.</p>\n<p>The disclosure clarifies governance responsibilities, identifying two committee chairs from the executive ranks—Guo Jinhong (Nomination and Strategic Committees)—and two from the independent non-executive cohort—Xie Rong (Audit) and Qin Ling (Remuneration and Evaluation). The structure reflects the company’s adherence to Hong Kong corporate governance practices that emphasize independent oversight across key Board functions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00570","symbol_name":"中国中药","start_time":0,"source_url":"","article_id":"1183809137","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183809137","pubTimestamp":1784295752,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Traditional Chinese Medicine Holdings Co. Limited released an updated roster of its Board of Directors and detailed the latest composition of its four Board committees as of 17 July 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00570":"中国中药"},"translate_title":"中国中药列出当前董事会和委员会阵容","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00570":1},"content_text":"China Traditional Chinese Medicine Holdings Co. Limited released an updated roster of its Board of Directors and detailed the latest composition of its four Board committees as of 17 July 2026.\nThe Board now comprises 12 directors:\n• Executive Directors (3): Chairman Guo Jinhong, Li Hongjian and Peng Li.  \n• Non-executive Directors (5): Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun and Huang Hao.  \n• Independent Non-executive Directors (4): Xie Rong, Yu Tze Shan Hailson, Qin Ling and Li Weidong.\nCommittee leadership and membership are as follows:\n1. Audit Committee – chaired by Independent Non-executive Director Xie Rong; members include Yu Tze Shan Hailson, Qin Ling and Li Weidong.  \n2. Remuneration and Evaluation Committee – chaired by Qin Ling; members are Li Hongjian, Xie Rong, Yu Tze Shan Hailson and Li Weidong.  \n3. Nomination Committee – chaired by Guo Jinhong; members include Li Hongjian, Xie Rong, Qin Ling and Li Weidong.  \n4. Strategic Committee – chaired by Guo Jinhong; members comprise Li Hongjian, Peng Li, Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun, Yu Tze Shan Hailson and Qin Ling.\nThe disclosure clarifies governance responsibilities, identifying two committee chairs from the executive ranks—Guo Jinhong (Nomination and Strategic Committees)—and two from the independent non-executive cohort—Xie Rong (Audit) and Qin Ling (Remuneration and Evaluation). The structure reflects the company’s adherence to Hong Kong corporate governance practices that emphasize independent oversight across key Board functions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183809137","isCrawlerRequest":true}